J
Jianming Xu
Researcher at Samsung Medical Center
Publications - 1
Citations - 644
Jianming Xu is an academic researcher from Samsung Medical Center. The author has contributed to research in topics: Sorafenib & Population. The author has an hindex of 1, co-authored 1 publications receiving 575 citations.
Papers
More filters
Journal ArticleDOI
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Philip J. Johnson,Shukui Qin,Joong-Won Park,Ronnie T.P. Poon,Jean-Luc Raoul,Philip A. Philip,Chih-Hung Hsu,Tsung Hui Hu,Jeong Heo,Jianming Xu,Ligong Lu,Yee Chao,Eveline Boucher,Kwang Hyub Han,Seung Woon Paik,Jorge Robles-Aviña,Masatoshi Kudo,Lunan Yan,Abhasnee Sobhonslidsuk,Dmitry Komov,Thomas Decaens,Won Young Tak,Long Bin Jeng,David R. Liu,Rana Ezzeddine,Ian Walters,Ann-Lii Cheng +26 more
TL;DR: Brivanib had an acceptable safety profile, but was less well-tolerated than sorafenib, and both agents had similar antitumor activity, based on secondary efficacy end points.